MetaCap

Arcturus Therapeutics (ARCT) vs Cypherpunk Technologies (CYPH)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Arcturus Therapeutics (ARCT) has outperformed Cypherpunk Technologies (CYPH) over the past year, gaining 19.0% versus a loss of 38.2%. Over five years, ARCT leads with a -81.3% price change compared with -94.4% for CYPH. Arcturus Therapeutics is the larger company by market cap ($214.7 million vs $210.1 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ARCT+19.01%CYPH-38.16%
+183%+46%-90%
Nov 21, 20251 yearNov 20, 2026
ARCT-79.56%CYPH-93.79%
+50%-28%-106%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ARCT versus CYPH key metrics
MetricARCTCYPH
Share price$7.45$1.41
Market cap$214.73M$210.15M
1-day change-1.97%-18.02%
YTD return+21.53%+21.55%
1-year return+19.01%-38.16%
5-year return-81.32%-94.45%
P/E ratio (TTM)—0.67
EPS (TTM)$-3.10$2.09
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$82.03M—
Revenue growth (YoY)-46.14%—
Net income (latest FY)$-65.78M$4.82M
Operating margin-92.96%—
Net margin-80.19%—
52-week high$17.96$4.19
52-week low$5.50$0.491
Distance from 52-week high-58.52%-66.35%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+218.12%+254.61%
Average volume851.45K15.42M
Shares outstanding28.82M149.04M
Employees1066
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ARCT has outperformed CYPH by 57.2 percentage points over the past year.

About Arcturus Therapeutics

ARCT stock →

Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system.

Health Care · Biotechnology: Pharmaceutical Preparations · 106 employees

About Cypherpunk Technologies

CYPH stock →

Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash.

Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees

ARCT vs CYPH FAQ

Which is bigger, Arcturus Therapeutics or Cypherpunk Technologies?

Arcturus Therapeutics (ARCT) is larger, with a market capitalization of $214.73M compared with $210.15M for Cypherpunk Technologies (CYPH).

Which stock has performed better over the past year, ARCT or CYPH?

ARCT returned +19.01% over the past 12 months, compared with -38.16% for CYPH (price return, excluding dividends). Past performance does not predict future results.

Are Arcturus Therapeutics and Cypherpunk Technologies in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons